Infectious Diseases and Antimicrobial Resistance
Infectious Diseases:
Infectious diseases are caused by pathogens such as bacteria, viruses, fungi, and parasites. They range from acute illnesses (e.g., influenza, COVID-19) to chronic infections (e.g., tuberculosis, HIV).
Key Challenges in Infectious Diseases:
- Emerging and Re-Emerging Pathogens:
- New infectious agents, such as SARS-CoV-2, or re-emerging diseases like measles due to vaccine hesitancy.
- Globalization and Travel:
- Accelerates the spread of infectious diseases across regions.
- Zoonotic Diseases:
- Increasing prevalence due to interactions between humans and animals (e.g., Ebola, avian influenza).
Antimicrobial Resistance (AMR):
AMR occurs when microorganisms evolve to resist the effects of antimicrobial drugs, rendering treatments less effective or ineffective. It is a significant global health threat.
Causes of AMR:
- Overuse of Antibiotics:
- Inappropriate prescriptions or over-the-counter sales.
- Misuse in Agriculture:
- Use of antibiotics in livestock and farming, promoting resistant strains.
- Inadequate Infection Control:
- Poor hygiene and sanitation in healthcare and community settings.
Related Conference of Infectious Diseases and Antimicrobial Resistance
Infectious Diseases and Antimicrobial Resistance Conference Speakers
Recommended Sessions
- Advanced Drug Delivery Systems
- Advances in Vaccine Technology
- Advances in Omics Technologies
- Artificial Intelligence in Biomedicine
- Biotechnology in Drug Development
- Cardiovascular Pharmacotherapy
- Clinical Pharmacology and Therapeutics
- Digital Health and Telemedicine
- Ethical Challenges and Regulatory Science in Healthcare and Pharmaceuticals
- Gene Therapy and Genetic Medicine
- Immunotherapy and Immunopharmacology
- Infectious Diseases and Antimicrobial Resistance
- Innovations in Biologics and Biosimilars
- Metabolic Disorders and Endocrinology
- Nanotechnology in Biomedicine
- Neuropharmacology and Neurotherapeutics
- Oncology Research and Therapeutics
- Paediatric and Geriatric Pharmacotherapy
- Pharmacogenomics and Personalized Medicine
- Pharmacovigilance and Drug Safety
- Public Health and Pharmacoeconomics
- Rare and Orphan Diseases: Therapeutic Approaches
- Rare Disease Therapeutics
- Regenerative Medicine and Tissue Engineering
- Respiratory and Pulmonary Pharmacotherapy
